Fair Value Calculator Fair Value Calculator
EN DE

BCCFUBA (BCCFUBA) Fair Value & Analysis

IN · Market cap ₹3.5B

B BCCFUBA BCCFUBA · BSE
Price₹175.55
Fair Value₹97.81
Upside-44.3%
Quality51/100
Watch BCCFUBA for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹60.56 – ₹126.57

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price +11.7% over the past month.

Price vs Fair Value (12 months)

₹218.85 ₹99.10 Fair Value ₹97.81 Jul 2025 Jul 2026

12‑month range ₹99.10 – ₹218.85 · fair‑value band ₹60.56 – ₹126.57 · the ₹175.55 price screens above the ₹97.81 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

BCCFUBA (BCCFUBA) currently trades at ₹175.55, while our model-based Fair Value estimate is ₹97.81 — implying the stock looks roughly 44.3% overvalued today. We read business quality at 51/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, BCCFUBA generated revenue of ₹727M at a net margin of 8.0%. Revenue grew 79.7% year over year. It earns a return on equity of 16.7%. Net debt stands at ₹119M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹60.56 (bear case) to ₹126.57 (bull case); at ₹175.55, the current price sits above that range. The share trades about 20% below its 52-week high and 84% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹727M
Revenue growth (YoY) +79.7%
Net margin 8.0%
Return on equity 16.7%
Free cash flow −₹2.1M FY2026
P/E ratio 56.3
More key figures
Operating margin 11.6%
EPS (TTM) ₹3.12
EPS growth (YoY) +47.5%
Net debt ₹119M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

BCCFUBA reported revenue of ₹727M in FY2026 versus ₹285M in FY2022, a compound +26.4%/yr. Reported net income was ₹58.2M in FY2026, compounding +59.9%/yr from FY2022.

Revenue +26.4%/yr
FY22 ₹285M
FY23 ₹286M
FY24 ₹323M
FY25 ₹471M
FY26 ₹727M
Net income +59.9%/yr
FY22 ₹8.9M
FY23 ₹23.0M
FY24 ₹37.6M
FY25 ₹37.4M
FY26 ₹58.2M

Is BCCFUBA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "BCCFUBA Fair Value". https://www.fairvalue-calculator.com/stock/BCCFUBA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is BCCFUBA (BCCFUBA) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹97.81 versus a price of ₹175.55 — about −44% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BCCFUBA?
Our model-based fair value for BCCFUBA is ₹97.81 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹175.55.
What is the quality score of BCCFUBA?
BCCFUBA has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of BCCFUBA (BCCFUBA)?
BCCFUBA reported trailing-twelve-month revenue of about ₹727M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of BCCFUBA?
The net profit margin of BCCFUBA is about 8.0%, meaning it keeps roughly 8.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.